149 related articles for article (PubMed ID: 60073)
1. 5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia.
Von Hoff DD; Slavik M; Muggia FM
Ann Intern Med; 1976 Aug; 85(2):237-45. PubMed ID: 60073
[TBL] [Abstract][Full Text] [Related]
2. [Possibilities for the clinical use of 5-azacytidine].
Veselý J; Cihák A
Vopr Onkol; 1977; 23(10):65-73. PubMed ID: 74127
[TBL] [Abstract][Full Text] [Related]
3. 5-azacytidine in refractory acute leukemia.
Case DC
Oncology; 1982; 39(4):218-21. PubMed ID: 6178065
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute leukemia with 5-azacytidine (NSC-102816).
McCredie KB; Bodey GP; Burgess MA; Gutterman JU; Rodriguez V; Sullivan MP; Freireich EJ
Cancer Chemother Rep; 1973; 57(3):319-23. PubMed ID: 4127393
[No Abstract] [Full Text] [Related]
5. 5-azacytidine--a new anticancer drug with significant activity in acute myeloblastic leukemia.
von Hoff DD; Slavik M
Adv Pharmacol Chemother; 1977; 14():285-326. PubMed ID: 70163
[No Abstract] [Full Text] [Related]
6. 5-Azacytidine (NSC 102816): a new drug for the treatment of myeloblastic leukemia.
Vogler WR; Miller DS; Keller JW
Blood; 1976 Sep; 48(3):331-7. PubMed ID: 60156
[TBL] [Abstract][Full Text] [Related]
7. 5-Azacytidine: a new active agent for the treatment of acute leukemia.
Karon M; Sieger L; Leimbrock S; Finklestein JZ; Nesbit ME; Swaney JJ
Blood; 1973 Sep; 42(3):359-65. PubMed ID: 4125239
[No Abstract] [Full Text] [Related]
8. 5-azacytidine in acute leukemia.
Saiki JH; McCredie KB; Vietti TJ; Hewlett JS; Morrison FS; Costanzi JJ; Stuckey WJ; Whitecar J; Hoogstraten B
Cancer; 1978 Nov; 42(5):2111-4. PubMed ID: 82472
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of 5-azacytidine in eukaryotes.
Cihák A
Oncology; 1974; 30(5):405-22. PubMed ID: 4142650
[TBL] [Abstract][Full Text] [Related]
10. 5-azacytidine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():37-46. PubMed ID: 6168559
[No Abstract] [Full Text] [Related]
11. [Mechanism of cystostatic effect of 5-azacytidine and its usefulness in clinic].
Veselý J; Cihák A
Cas Lek Cesk; 1975 May; 114(20):607-11. PubMed ID: 48423
[No Abstract] [Full Text] [Related]
12. Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.
Beisler JA; Abbasi MM; Kelley JA; Driscoll JS
J Med Chem; 1977 Jun; 20(6):806-12. PubMed ID: 69026
[No Abstract] [Full Text] [Related]
13. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice.
Neil GL; Moxley TE; Kuentzel SL; Manak RC; Hanka LJ
Cancer Chemother Rep; 1975; 59(3):459-65. PubMed ID: 54211
[TBL] [Abstract][Full Text] [Related]
14. [Clinical pharmacology of 5-azacytidine].
Robak T
Pol Tyg Lek; 1984 Feb; 39(7):215-8. PubMed ID: 6205386
[No Abstract] [Full Text] [Related]
15. A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults with acute nonlymphocytic leukemia.
Levi JA; Wiernik PH
Cancer; 1976 Jul; 38(1):36-41. PubMed ID: 59627
[TBL] [Abstract][Full Text] [Related]
16. [6-Thioguanine in the chemotherapy of leukemias].
Zidermane AA
Vopr Onkol; 1979; 25(1):74-83. PubMed ID: 284664
[No Abstract] [Full Text] [Related]
17. 5-Azacytidine: acute central nervous system toxicity.
Weisman SJ; Berkow RL; Weetman RM; Baehner RL
Am J Pediatr Hematol Oncol; 1985; 7(1):86-8. PubMed ID: 2412461
[No Abstract] [Full Text] [Related]
18. High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
Van Echo DA; Wiernik PH; Aisner J
Cancer Clin Trials; 1980; 3(4):325-8. PubMed ID: 6933027
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute leukemia and chronic myelogenous leukemia in blastic phase.
Wilhelm M; O'Brien S; Rios MB; Estey E; Keating MJ; Plunkett W; Sorenson M; Kantarjian HM
Leuk Lymphoma; 1999 Aug; 34(5-6):511-8. PubMed ID: 10492074
[TBL] [Abstract][Full Text] [Related]
20. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
Leventhal BG; Skeel RT; Yankee RA; Henderson ES
Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
